An International Patient-led Registry in Fibrotic Interstitial Lung Diseases Using eHealth Technology

NCT04304898 | Recruiting

• 1 other identifier: MEC-2020-0029
• Study Type: observational
• Target: 700
• Locations: 1 country
• Sites: 2

Brief Summary

The I-FILE study is a prospective multicenter, multinational observational study where the feasibility of a patient-led registry using home monitoring in patients with pulmonary fibrosis will be evaluated. The aim of the study is to gain more insights in disease behavior in patients with pulmonary fibrosis, so in future patients with progressive disease can be better identified.

Conditions

Pulmonary Fibrosis

Keywords

eHealth; home spirometry

Outcome Measures

Primary Outcomes (47)

• Forced Vital Capacity (FVC) home spirometry

  FVC change measured with home spirometry and saturation at 6 months (in % and L)

  6 months after inclusion

• Forced Vital Capacity (FVC) home spirometry

  FVC change measured with home spirometry and saturation at 12 months (in % and L)

  12 months after inclusion

• Forced Vital Capacity (FVC) home spirometry

  FVC change measured with home spirometry and saturation at 24 months (in % and L)

  24 months after inclusion

• Forced Vital Capacity (FVC) hospital spirometry

  FVC change measured with hospital spirometry and saturation at 6 months (in % and L)

  6 months after inclusion

• Forced Vital Capacity (FVC) hospital spirometry

  FVC change measured with hospital spirometry and saturation at 12 months (in % and L)

  12 months after inclusion

• Forced Vital Capacity (FVC) hospital spirometry

  FVC change measured with hospital spirometry and saturation at 24 months (in % and L)

  24 months after inclusion

• Adherence to daily home spirometry

  The percentage of patients completed daily home spirometry

  3 months after inclusion

• Adherence to weekly home spirometry

  The percentage of patients completed weekly home spirometry

  2 years after inclusion

• L-PF Impacts

  • Living with Pulmonary Fibrosis: 21-item questionnaire which assess the way pulmonary fibrosis has impact on quality of life. Total scores range from 0-4, with a higher score indicating more impact of lung fibrosis on the quality of life.

  Baseline

• K-BILD

  • King's brief Interstitial Lung Disease Health Status: The K-BILD health status questionnaire is a 15 item validated, self-completed heath status questionnaire. It has three domains: breathlessness and activities, psychological and chest symptoms. The K-BILD domain and total score ranges are 0-100, with the higher scores corresponding with better HRQOL. It will take about 3 minutes to complete this questionnaire.

  Baseline

• EQ5D

  • The EuroQol five dimensions 5-level questionnaire: 6-item questionnaire on five dimensions: The EuroQol five dimensions 5-level questionnaire is a standardized instrument to measures health outcomes in two components: health description and valuation. It comprises five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Higher score indicates a poorer health status.

  Baseline

• VAS

  • Visual Analogue Scale: scores on fatigue, dyspnea, cough and general wellbeing on a scale ranging from 0-10. Higher score indicates more complaint.

  Baseline

• LCQ

  • Leicester Cough Questionnaire: Cough-specific, health related quality of life is assessed with the Leicester Cough Questionnaire (LCQ), a 19-item questionnaire that has been validated in acute and chronic cough. The overall score ranges from 3 to 21 with a higher score indicating a better quality of life. It will take about 4 minutes to complete the questionnaire.

  Baseline

• FAS

  • Fatigue Assessment Scale: 10-item questionnaire about fatigue FAS. The fatigue assessment scale (FAS) is a 10-item self-administered questionnaire about fatigue in patients with sarcoidosis. The score ranges from 5-50 points, with a score of ≥ 22 points as cut-off for fatigue. The minimal important difference (MID) is 4 points or a 10% lower score. It will take about 1-2 minutes to complete.

  Baseline

• WPAI

  • Work Productivity and Activity Impairment Questionnaire: General Health (WPAI) All patients in the working age population will complete this questionnaire which assess loss of work productivity due to disease in six questions .It will take about 2-3 minutes to complete. WPAI outcomes are expressed as impairment percentages, with higher numbers indicating greater impairment and less productivity.

  Baseline

• GRoC

  • Global Rating of Change Scales: Global rating of change (GRC) scales provide a method of obtaining information about improving or deteriorated of health condition of patients over time. Patients are asked to make global ratings on changes in regards to their well-being on a 15-point self-report scale (from -7 to 7 ). It will take about 1 minute to complete. Higher score indicates a better health condition.

  Baseline

• L-PF Impacts

  • Living with Pulmonary Fibrosis: 21-item questionnaire which assess the way pulmonary fibrosis has impact on quality of life. Total scores range from 0-4, with a higher score indicating more impact of lung fibrosis on the quality of life.

  After 12 months

• K-BILD

  • King's brief Interstitial Lung Disease Health Status: The K-BILD health status questionnaire is a 15 item validated, self-completed heath status questionnaire. It has three domains: breathlessness and activities, psychological and chest symptoms. The K-BILD domain and total score ranges are 0-100, with the higher scores corresponding with better HRQOL. It will take about 3 minutes to complete this questionnaire.

  After 12 months

• EQ5D

  • The EuroQol five dimensions 5-level questionnaire: 6-item questionnaire on five dimensions: The EuroQol five dimensions 5-level questionnaire is a standardized instrument to measures health outcomes in two components: health description and valuation. It comprises five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Higher score indicates a poorer health status.

  After 12 months

• VAS

  • Visual Analogue Scale: scores on fatigue, dyspnea, cough and general wellbeing on a scale ranging from 0-10. Higher score indicates more complaint.

  After 12 months

• LCQ

  • Leicester Cough Questionnaire: Cough-specific, health related quality of life is assessed with the Leicester Cough Questionnaire (LCQ), a 19-item questionnaire that has been validated in acute and chronic cough. The overall score ranges from 3 to 21 with a higher score indicating a better quality of life. It will take about 4 minutes to complete the questionnaire.

  After 12 months

• FAS

  • Fatigue Assessment Scale: 10-item questionnaire about fatigue FAS. The fatigue assessment scale (FAS) is a 10-item self-administered questionnaire about fatigue in patients with sarcoidosis. The score ranges from 5-50 points, with a score of ≥ 22 points as cut-off for fatigue. The minimal important difference (MID) is 4 points or a 10% lower score. It will take about 1-2 minutes to complete.

  After 12 months

• WPAI

  • Work Productivity and Activity Impairment Questionnaire: General Health (WPAI) All patients in the working age population will complete this questionnaire which assess loss of work productivity due to disease in six questions .It will take about 2-3 minutes to complete. WPAI outcomes are expressed as impairment percentages, with higher numbers indicating greater impairment and less productivity.

  After 12 months

• GRoC

  • Global Rating of Change Scales: Global rating of change (GRC) scales provide a method of obtaining information about improving or deteriorated of health condition of patients over time. Patients are asked to make global ratings on changes in regards to their well-being on a 15-point self-report scale (from -7 to 7 ). It will take about 1 minute to complete. Higher score indicates a better health condition.

  After 12 months

• L-PF Impacts

  • Living with Pulmonary Fibrosis: 21-item questionnaire which assess the way pulmonary fibrosis has impact on quality of life. Total scores range from 0-4, with a higher score indicating more impact of lung fibrosis on the quality of life.

  After 24 months

• K-BILD

  • King's brief Interstitial Lung Disease Health Status: The K-BILD health status questionnaire is a 15 item validated, self-completed heath status questionnaire. It has three domains: breathlessness and activities, psychological and chest symptoms. The K-BILD domain and total score ranges are 0-100, with the higher scores corresponding with better HRQOL. It will take about 3 minutes to complete this questionnaire.

  After 24 months

• EQ5D

  • The EuroQol five dimensions 5-level questionnaire: 6-item questionnaire on five dimensions: The EuroQol five dimensions 5-level questionnaire is a standardized instrument to measures health outcomes in two components: health description and valuation. It comprises five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Higher score indicates a poorer health status.

  After 24 months

• VAS

  • Visual Analogue Scale: scores on fatigue, dyspnea, cough and general wellbeing on a scale ranging from 0-10. Higher score indicates more complaint.

  After 24 months

• LCQ

  • Leicester Cough Questionnaire: Cough-specific, health related quality of life is assessed with the Leicester Cough Questionnaire (LCQ), a 19-item questionnaire that has been validated in acute and chronic cough. The overall score ranges from 3 to 21 with a higher score indicating a better quality of life. It will take about 4 minutes to complete the questionnaire.

  After 24 months

• FAS

  • Fatigue Assessment Scale: 10-item questionnaire about fatigue FAS. The fatigue assessment scale (FAS) is a 10-item self-administered questionnaire about fatigue in patients with sarcoidosis. The score ranges from 5-50 points, with a score of ≥ 22 points as cut-off for fatigue. The minimal important difference (MID) is 4 points or a 10% lower score. It will take about 1-2 minutes to complete.

  After 24 months

• WPAI

  • Work Productivity and Activity Impairment Questionnaire: General Health (WPAI) All patients in the working age population will complete this questionnaire which assess loss of work productivity due to disease in six questions .It will take about 2-3 minutes to complete. WPAI outcomes are expressed as impairment percentages, with higher numbers indicating greater impairment and less productivity.

  After 24 months

• GRoC

  • Global Rating of Change Scales: Global rating of change (GRC) scales provide a method of obtaining information about improving or deteriorated of health condition of patients over time. Patients are asked to make global ratings on changes in regards to their well-being on a 15-point self-report scale (from -7 to 7 ). It will take about 1 minute to complete. Higher score indicates a better health condition.

  After 24 months

• Time to change of L-PF Impacts

  • Living with Pulmonary Fibrosis: 21-item questionnaire which assess the way pulmonary fibrosis has impact on quality of life. Total scores range from 0-4, with a higher score indicating more impact of lung fibrosis on the quality of life.

  2 years

• Time to change of K-BILD

  • King's brief Interstitial Lung Disease Health Status: The K-BILD health status questionnaire is a 15 item validated, self-completed heath status questionnaire. It has three domains: breathlessness and activities, psychological and chest symptoms. The K-BILD domain and total score ranges are 0-100, with the higher scores corresponding with better HRQOL. It will take about 3 minutes to complete this questionnaire.

  2 years

• Time to change of EQ5D

  • The EuroQol five dimensions 5-level questionnaire: 6-item questionnaire on five dimensions: The EuroQol five dimensions 5-level questionnaire is a standardized instrument to measures health outcomes in two components: health description and valuation. It comprises five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Higher score indicates a poorer health status.

  2 years

• Time to change of VAS

  • Visual Analogue Scale: scores on fatigue, dyspnea, cough and general wellbeing on a scale ranging from 0-10. Higher score indicates more complaint.

  2 years

• Time to change of LCQ

  • Leicester Cough Questionnaire: Cough-specific, health related quality of life is assessed with the Leicester Cough Questionnaire (LCQ), a 19-item questionnaire that has been validated in acute and chronic cough. The overall score ranges from 3 to 21 with a higher score indicating a better quality of life. It will take about 4 minutes to complete the questionnaire.

  2 years

• Time to change of FAS

  • Fatigue Assessment Scale: 10-item questionnaire about fatigue FAS. The fatigue assessment scale (FAS) is a 10-item self-administered questionnaire about fatigue in patients with sarcoidosis. The score ranges from 5-50 points, with a score of ≥ 22 points as cut-off for fatigue. The minimal important difference (MID) is 4 points or a 10% lower score. It will take about 1-2 minutes to complete.

  2 years

• Time to change of WPAI

  • Work Productivity and Activity Impairment Questionnaire: General Health (WPAI) All patients in the working age population will complete this questionnaire which assess loss of work productivity due to disease in six questions .It will take about 2-3 minutes to complete. WPAI outcomes are expressed as impairment percentages, with higher numbers indicating greater impairment and less productivity.

  2 years

• Time to change of GRoC

  • Global Rating of Change Scales: Global rating of change (GRC) scales provide a method of obtaining information about improving or deteriorated of health condition of patients over time. Patients are asked to make global ratings on changes in regards to their well-being on a 15-point self-report scale (from -7 to 7 ). It will take about 1 minute to complete. Higher score indicates a better health condition.

  2 years

• Predictors

  Predictors of disease progression and mortality

  2 years

• FVC change hospital-based and home spirometry

  Correlations between FVC change between home and hospital-based spirometry

  2 years

• FVC change and HRQOL and symptom changes

  Correlations between FVC change and HRQOL and symptom changes

  12 months

• FVC change and HRQOL and symptom changes

  Correlations between FVC change and HRQOL and symptom changes

  24 months

• Differences in adherence between countries

  Differences in adherence, FVC change, HRQOL and mortality between countries

  2 years

• Healthcare provider and patient satisfaction

  Healthcare provider and patient satisfaction and experience with the online application. Patients and healthcare providers are asked about their experiences and opinions on homemonitoring.

  2 years

• Mortality

  Mortality

  2 years

Study Arms (1)

Single Group Assignment

Intervention group without a control group

Other: Home spirometry

Interventions

Home spirometry OTHER

* Patients will perform daily home spirometry for three months with a Bluetooth-enabled validated, CE-marked home spirometer (Spiro bank Smart, MIR, Italy). Subsequently, patients will perform weekly home spirometry for two years in total. During this period, patients will be asked to perform three measurements each week on the same day. * Hospital-based spirometry will be performed according to international guidelines. * Patients will complete patient-reported outcomes (PROMs) online in the secured application every six months.

Single Group Assignment

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

500 untreated patients with a diagnosis of F-ILD in ILD expert centers in 5 European countries

You may qualify if:

• Newly diagnosed patients with F-ILD according to the ATS/ERS criteria by a multidisciplinary ILD team :
• Treatment for F-ILD ≤ than 1 month

You may not qualify if:

• Not able to speak, read or write in the native language of the country where the patient is included
• Not able to comply to the study protocol, according to the judgement of the investigator and/or patient
• No access to internet

Sponsors & Collaborators

• Erasmus Medical Center: lead

Study Sites (2)

Erasmus MC

Rotterdam, South Holland, 3015 CE, Netherlands

RECRUITING

Erasmus MC

Rotterdam, Netherlands

RECRUITING

Related Publications (1)

• Nakshbandi G, Moor CC, Antoniou K, Cottin V, Hoffmann-Vold AM, Koemans EA, Kreuter M, Molyneaux PL, Wuyts WA, Wijsenbeek MS. Study protocol of an international patient-led registry in patients with pulmonary fibrosis using online home monitoring: I-FILE. BMC Pulm Med. 2023 Feb 2;23(1):51. doi: 10.1186/s12890-023-02336-4.

  PMID: 36732734 DERIVED

MeSH Terms

Conditions

Pulmonary Fibrosis

Condition Hierarchy (Ancestors)

Lung Diseases, Interstitial; Lung Diseases; Respiratory Tract Diseases; Fibrosis; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Marlies Wijsenbeek, MD PhD

  Erasmus Medical Center

  PRINCIPAL INVESTIGATOR

• Wim Wuyts, MD PhD

  Universitair Ziekenhuis Leuven

  PRINCIPAL INVESTIGATOR

• Anna-Maria Hoffmann-Vold, MD PhD

  Oslo University Hospital

  PRINCIPAL INVESTIGATOR

• Michael Kreuter, MD PhD

  Interdisciplinary Center for Sarcoidosis, Thoraxklinik, University Hospital Heidelberg

  PRINCIPAL INVESTIGATOR

• Philip Molyneaux, MD PhD

  Royal Brompton Hospital, Guys and St Thomas' Hospital NHS Foundation Trust.

  PRINCIPAL INVESTIGATOR

• Vincent Cottin, MD PhD

  Service de pneumologie, hôpital Louis Pradel, Hospices Civils de Lyon

  PRINCIPAL INVESTIGATOR

• Katarina Antoniou

  Laboratory of Molecular and Cellular Pneumonology, Respiratory Medicine Department, School of Medicine, University of Crete, Heraklion, Greece

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Marlies Wijsenbeek, MD PhD

CONTACT

+31107030323; m.wijsenbeek-lourens@erasmusmc.nl

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Target Duration: 2 Years
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal investigator

Study Record Dates

• First Submitted: March 9, 2020
• First Posted: March 12, 2020
• Study Start: May 1, 2020
• Primary Completion: July 1, 2025
• Study Completion (Estimated): July 1, 2026
• Last Updated: March 20, 2024

Record last verified: 2024-03

Locations

NL (2)